HR 2298
105th Congress
House
To improve the regulation of radiopharmaceuticals.
Health
Administrative procedureDepartment of Health and Human ServicesDrug approvalsDrug utilization
More subjectsShow fewer subjects
DrugsEnvironmental ProtectionGovernment Operations and PoliticsLawMedical testsPharmaceutical researchRadiation safetyRadioisotopes in medicineRisk assessmentScience, Technology, Communications
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 18, 1997
Referred to the Subcommittee on Health and Environment.
Jul 30, 1997
Referred to the House Committee on Commerce.
Jul 30, 1997
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health and Environment.
Plain-English summary
Directs the Secretary of Health and Human Services to issue regulations regarding the approval of radiopharmaceuticals designed for diagnosis and monitoring of diseases and conditions.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cosponsors
3
Cite this page
U.S. Congress. (2026). H.R. 2298: To improve the regulation of radiopharmaceuticals.. 105th Congress. Open America. https://openamerica.io/bill/105-HR-2298/
"H.R. 2298: To improve the regulation of radiopharmaceuticals.." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-HR-2298/.
H.R. 2298, 105th Cong. (2026), https://openamerica.io/bill/105-HR-2298/.
[H.R. 2298: To improve the regulation of radiopharmaceuticals.](https://openamerica.io/bill/105-HR-2298/)